TMEM16A deficiency in alveolar type 2 epithelial cells protected against endoplasmic reticulum stress-induced ferroptosis during acute lung injury
Organizations involved: sponsor pharma/biotech, clinical research organizations (CROs) running trials, clinical sites and investigators, central labs, data monitoring boards, regulatory agencies (FDA, EMA, PMDA, NMPA, CDSCO), and regulatory consultants for dossier preparation Patient Support & Services After approval, the focus shifts to market access, pricing, and reimbursement negotiations with healthcare payers
Introduction to GLP-1s In the pursuit of better health, understanding how our body regulates appetite, blood sugar, and metabolism is crucial
Brame CJ, Boutaud O, Davies SS, Yang T, Oates JA, Roden D et al